# tACS for Amyloid-β Reduction in Alzheimer's Disease

> **NCT03290326** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 17 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** Transcranial Alternating Current Stimulation (tACS)

## Key facts

- **NCT ID:** NCT03290326
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2019-05-14
- **Final completion:** 2019-05-14
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03290326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03290326, "tACS for Amyloid-β Reduction in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03290326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*